Ravulizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Currently Treated With High-Dose Eculizumab
Clinical trial NCT04320602 · COMPLETED
Trial details
- NCT number
- NCT04320602
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-14
- Primary completion
- 2022-12-20
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.